International Immunopharmacology ( IF 5.6 ) Pub Date : 2020-07-16 , DOI: 10.1016/j.intimp.2020.106457 Jun Xu 1 , Liang Ma 2 , Ping Fu 2
Backgrounds
Contrast-induced acute kidney injury (CIAKI) is the third most common cause of hospital-acquired AKI. It has been demonstrated that microRNA-30c (miR-30c) was upregulated in the CIAKI. However, the underlying mechanism remain unclear.
Methods
The CIAKI was induced in miniature pig. The expression profile of miR-30c in the kidney was evaluated by qPCR. The pathways regulated by miR-30c was identified by qPCR and western blot on renal tubular epithelial cells isolated from miniature pig. Finally, the potential therapeutic application of targeting miR-30c was assessed in the pig model of CIAKI.
Results
The miR-30c was up-regulated in miniature pig with CIAKI. The miR-30c suppressed cell apoptosis, expression of NLRP3, the secretion of IL-1β and caspase-1 p10 on renal cells stimulated by iohexol in vitro. In the pig model, miR-30c inhibited the CIAKI development.
Conclusion
Our data demonstrated that the miR-30c induced by CIAKI could suppress cell apoptosis and kidney injury via targeting NLRP3. Therefore, targeting miR-30c might be a novel therapeutic candidate for CIAKI treatment and prevention.
中文翻译:
MicroRNA-30c通过抑制NLRP3炎症小体来减轻造影剂引起的急性肾脏损伤。
背景资料
造影剂引起的急性肾损伤(CIAKI)是医院获得性AKI的第三大最常见原因。已经证明在CIAKI中microRNA-30c(miR-30c)被上调。但是,其潜在机制仍不清楚。
方法
CIAKI是在小型猪中诱导的。通过qPCR评估miR-30c在肾脏中的表达谱。在分离自小型猪的肾小管上皮细胞上,通过qPCR和Western blot鉴定了miR-30c调控的途径。最后,在CIAKI的猪模型中评估了靶向miR-30c的潜在治疗应用。
结果
CIAKI在微型猪中上调了miR-30c。miR-30c抑制了碘海醇在体外刺激肾细胞的细胞凋亡,NLRP3表达,IL-1β和caspase-1 p10的分泌。在猪模型中,miR-30c抑制了CIAKI的发育。
结论
我们的数据表明,CIAKI诱导的miR-30c可通过靶向NLRP3抑制细胞凋亡和肾脏损伤。因此,靶向miR-30c可能是CIAKI治疗和预防的新型治疗候选药物。